TIMIZA90 Project Factsheet

Ideas & Impact › Resources › TIMIZA90 Project Factsheet

Timiza90 is a five-year (Oct 2016 to Sept 2021) U.S. Centres for Disease Control and Prevention (CDC)-funded Project which aims to support the implementation and expansion of high quality, sustainable, and comprehensive HIV prevention, care, and treatment programs.

Explore Related Resources

Search More Resources

Resource

Protecting Lives, Sustaining Progress

Published March 2026

The following landscape analysis of maternal and child health, HIV prevention, diagnosis, and treatment, and the historic strength of U.S. leadership in global aid provides an overview of these key areas of global health and recommendations for U.S. Congressional engagement and prioritization.

Topics:

Advocacy,

Children,

Global Health Security,

Health System Strengthening,

HIV,

Maternal and Child Health,

Mothers and Infants,

Women

Journal Articles

Assessing Time Requirements of Two Models of SARS-CoV- 2 Screening and Testing in Routine Healthcare Services in Kenya and Cameroon

Published March 2025

Introduction Incorporating SARS-CoV-2 antigen-detecting rapid diagnostic tests (Ag-RDTs) into routine care settings can facilitate efficient case identification and management in low-resource settings. We assessed the time required to complete SARS-CoV-2 screening and Ag-RDT testing in maternal, neonatal and child health (MNCH), HIV and tuberculosis clinics in selected facilities in Kenya and Cameroon. Methods We conducted […]

Countries:

Cameroon,

Kenya

Journal Articles

A Cross-Sectional Study of the Use of Antigen Rapid Diagnostic Tests for Community Identification of Severe Acute Respiratory Syndrome Coronavirus-2 in Kenya

Published January 2025

Overview Mass testing with antigen-detecting rapid diagnostic tests (Ag-RDT), including testing of asymptomatic individuals, is expected to improve the identification of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections. Mass testing was offered at large gatherings to determine the SARS-CoV-2 case detection rate and the acceptance and cost of implementing this community testing strategy. In 49 […]